Our Story
CardioNexus AI is an emerging U.S.-based health technology company, set to revolutionize cardiovascular diagnostics through the innovative application of artificial intelligence (AI) in medical imaging. Founded by Abdelrahman Freek, the company is positioned to transform how healthcare providers utilize advanced imaging data to diagnose, monitor, and treat cardiovascular diseases.
At the core of CardioNexus AI's vision is the integration of deep learning, cardiovascular imaging, and computational clinical research. The company plans to build AI frameworks capable of interpreting high-resolution imaging data across a variety of modalities, including echocardiography, cardiac CT, MRI, and nuclear imaging, with clinical-grade accuracy and real-time efficiency.
CardioNexus AI is committed to building its infrastructure within secure, HIPAA-compliant cloud environments, ensuring scalability, availability, and seamless integration with diverse clinical workflows across the U.S. Focused on scientific rigor, the company will continually refine its models to advance the state of cardiovascular care.